Human KCNJ2/ATFB9/HHBIRK1 ORF/cDNA clone-Adenovirus particle (NM_000891)
Cat. No.: vGMAD000757
Pre-made Human KCNJ2/ATFB9/HHBIRK1 Adenovirus for KCNJ2 overexpression in-vitro and in-vivo. The KCNJ2 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified KCNJ2-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
Kir2.1/KCNJ2/KCNJ2/ATFB9 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAD000757 | Human KCNJ2 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAD000757 |
| Gene Name | KCNJ2 |
| Accession Number | NM_000891 |
| Gene ID | 3759 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1284 bp |
| Gene Alias | ATFB9,HHBIRK1,HHIRK1,IRK1,KIR2.1,LQT7,SQT3 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGGGCAGTGTGCGAACCAACCGCTACAGCATCGTCTCTTCAGAAGAAGACGGTATGAAGTTGGCCACCATGGCAGTTGCAAATGGCTTTGGGAACGGGAAGAGTAAAGTCCACACCCGACAACAGTGCAGGAGCCGCTTTGTGAAGAAAGATGGCCACTGTAATGTTCAGTTCATCAATGTGGGTGAGAAGGGGCAACGGTACCTCGCAGACATCTTCACCACGTGTGTGGACATTCGCTGGCGGTGGATGCTGGTTATCTTCTGCCTGGCTTTCGTCCTGTCATGGCTGTTTTTTGGCTGTGTGTTTTGGTTGATAGCTCTGCTCCATGGGGACCTGGATGCATCCAAAGAGGGCAAAGCTTGTGTGTCCGAGGTCAACAGCTTCACGGCTGCCTTCCTCTTCTCCATTGAGACCCAGACAACCATAGGCTATGGTTTCAGATGTGTCACGGATGAATGCCCAATTGCTGTTTTCATGGTGGTGTTCCAGTCAATCGTGGGCTGCATCATCGATGCTTTCATCATTGGCGCAGTCATGGCCAAGATGGCAAAGCCAAAGAAGAGAAACGAGACTCTTGTCTTCAGTCACAATGCCGTGATTGCCATGAGAGACGGCAAGCTGTGTTTGATGTGGCGAGTGGGCAATCTTCGGAAAAGCCACTTGGTGGAAGCTCATGTTCGAGCACAGCTCCTCAAATCCAGAATTACTTCTGAAGGGGAGTATATCCCTCTGGATCAAATAGACATCAATGTTGGGTTTGACAGTGGAATCGATCGTATATTTCTGGTGTCCCCAATCACTATAGTCCATGAAATAGATGAAGACAGTCCTTTATATGATTTGAGTAAACAGGACATTGACAACGCAGACTTTGAAATCGTGGTCATACTGGAAGGCATGGTGGAAGCCACTGCCATGACGACACAGTGCCGTAGCTCTTATCTAGCAAATGAAATCCTGTGGGGCCACCGCTATGAGCCTGTGCTCTTTGAAGAGAAGCACTACTACAAAGTGGACTATTCCAGGTTCCACAAAACTTACGAAGTCCCCAACACTCCCCTTTGTAGTGCCAGAGACTTAGCAGAAAAGAAATATATCCTCTCAAATGCAAATTCATTTTGCTATGAAAATGAAGTTGCCCTCACAAGCAAAGAGGAAGACGACAGTGAAAATGGAGTTCCAGAAAGCACTAGTACGGACACGCCCCCTGACATAGACCTTCACAACCAGGCAAGTGTACCTCTAGAGCCCAGGCCCTTACGGCGAGAGTCGGAGATATGA |
| ORF Protein Sequence | MGSVRTNRYSIVSSEEDGMKLATMAVANGFGNGKSKVHTRQQCRSRFVKKDGHCNVQFINVGEKGQRYLADIFTTCVDIRWRWMLVIFCLAFVLSWLFFGCVFWLIALLHGDLDASKEGKACVSEVNSFTAAFLFSIETQTTIGYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNETLVFSHNAVIAMRDGKLCLMWRVGNLRKSHLVEAHVRAQLLKSRITSEGEYIPLDQIDINVGFDSGIDRIFLVSPITIVHEIDEDSPLYDLSKQDIDNADFEIVVILEGMVEATAMTTQCRSSYLANEILWGHRYEPVLFEEKHYYKVDYSRFHKTYEVPNTPLCSARDLAEKKYILSNANSFCYENEVALTSKEEDDSENGVPESTSTDTPPDIDLHNQASVPLEPRPLRRESEI |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T74570-Ab | Anti-KCNJ2/ ATFB9/ HHBIRK1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T74570-Ag | KCNJ2 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP003142 | Human KCNJ2 Lentivirus plasmid |
| ORF Viral Vector | pGMAD000757 | Human KCNJ2 Adenovirus plasmid |
| ORF Viral Vector | pGMAD000836 | Human KCNJ2 Adenovirus plasmid |
| ORF Viral Vector | vGMLP003142 | Human KCNJ2 Lentivirus particle |
| ORF Viral Vector | vGMAD000757 | Human KCNJ2 Adenovirus particle |
| ORF Viral Vector | vGMAD000836 | Human KCNJ2 Adenovirus particle |
Target information
| Target ID | GM-T74570 |
| Target Name | Kir2.1/KCNJ2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3759 |
| Gene ID |
100052953 (Equus caballus), 101090306 (Felis catus), 16518 (Mus musculus), 281883 (Bos taurus) 29712 (Rattus norvegicus), 3759 (Homo sapiens), 403717 (Canis lupus familiaris), 574189 (Macaca mulatta) |
| Gene Symbols & Synonyms | KCNJ2,Kcnj2,KIR2.1,IRK1,Kcnf1,Kir2.1,LQT7,SQT3,ATFB9,HHIRK1,HHBIRK1 |
| Target Alternative Names | ATFB9,Cardiac inward rectifier potassium channel,HHBIRK1,HHIRK1,IRK1,Inward rectifier K(+) channel Kir2.1 (IRK-1,Inward rectifier potassium channel 2,KCNJ2,KIR2.1,Kcnf1,Kcnj2,Kir2.1,LQT7,Potassium channel,SQT3,hIRK1),inwardly rectifying subfamily J member 2 |
| Uniprot Accession |
O19182,P35561,P63252,P63253,Q64273,Q9MYY9
Additional SwissProt Accessions: P35561,O19182,Q64273,P63252,Q9MYY9,P63253 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Cholinergic synapse, Oxytocin signaling pathway, Renin secretion, Gastric acid secretion |
| Gene Ensembl | ENSECAG00000007922, ENSMUSG00000041695, ENSBTAG00000008294, ENSG00000123700, ENSCAFG00845005439, ENSMMUG00000056768 |
| Target Classification | Ion Channel |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


